Feature

CMS proposes exempting more practices from MACRA


 

The Centers for Medicare & Medicaid Services seeks to exempt more practices participating in Medicare’s Quality Payment Program, the value-based payment program created by Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

Currently, physicians who receive $30,000 or less in Medicare Part B payments or have 100 or fewer Medicare patients are exempt from QPP but may choose to participate. The proposed rule for the second year of QPP (calendar year 2018) would raise the threshold to $90,000 or less in Part B payments or 200 or fewer Medicare patients. The proposed rule was released June 20.

TheaDesign/Thinkstock
The proposal is part of a broader update rule designed to further reduce the potential QPP administrative burdens.

Under QPP, physicians and practices that are not exempt will choose one of two tracks – the Merit-Based Incentive Payment System (MIPS), which will pay bonuses based on meeting certain quality thresholds, or the advanced alternative payment models (APMs), under which physicians will assume more risk in exchange for greater potential rewards for quality improvement.

“We’ve heard the concerns that too many quality programs, technology requirements, and measures get between the doctor and the patient,” CMS Administrator Seema Verma said in a statement. “That’s why we’re taking a hard look at reducing burdens. By proposing this rule, we aim to improve Medicare by helping doctors and clinicians concentrate on caring for their patients rather than filling out paperwork.”

The proposed rule also introduces the framework for the development of “virtual groups,” a mechanism by which small and solo practices who meet the eligibility requirements for participating in MIPS can pool their reporting into the program to make it easier to share in the bonuses for meeting quality thresholds.

Recommended Reading

Supreme Court: Faith-based hospitals are exempt from federal pension requirements
MDedge Endocrinology
Supreme Court rules to speed biosimilar drugs to market
MDedge Endocrinology
Maryland passes generic drug anti–price gouging law
MDedge Endocrinology
The perils of the National Practitioner Data Bank
MDedge Endocrinology
EHR Report: Don’t let the electronic health record do the driving
MDedge Endocrinology
Average cost of Healthcare.gov policy up 105% since 2013
MDedge Endocrinology
What’s driving the ‘failure’ of the ACA marketplaces?
MDedge Endocrinology
Ear to the door: Five things being weighed in secret health bill also weigh it down
MDedge Endocrinology
KHN Exclusive: White House task force echoes Pharma proposals
MDedge Endocrinology
Survey: Most doctors would pick single payer over ACA, ACHA
MDedge Endocrinology